Daniel A. F. van Den Heuvel

Daniel A. F. van Den Heuvel

Auto-generated profile, based on publicly available information

Daniel A. F. van Den Heuvel

Department of Radiology, St Antonius Hospital, Nieuwegein, The Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2023 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
AUAlessandro Ucci
Alessandro Ucci
PPPaolo Perini
Paolo Perini
AFAntonio Freyrie
Antonio Freyrie
MSMichiel A. Schreve
Michiel A. Schreve
ÇÜÇağdaş Ünlü
Çağdaş Ünlü
RFRoberto Ferraresi
Roberto Ferraresi
Background: Chronic limb-threatening ischemia (CLTI) is known for its high rates of major amputation and mortality. Conventional revascularization techniques often fail in CLTI patients due to the heavily diseased arteries. Foot vein arterialization (FVA) has been proposed as an alternative technique to provide arterial blood to the foot by using the disease-free venous bed. Objectives: This systematic review and meta-analysis aimed to determine outcomes of surgical FVA (sFVA) and percutaneous FVA (pFVA) at 6 and 12 months post-procedure. Data sources: PubMed, Scopus, Web of Science, and the Cochrane Library databases were searched to identify papers reporting clinical outcomes of sFVA and pFVA published between January 1966 and March 2023. Methods: Databases were searched for eligible studies. A meta-analysis was performed to evaluate the limb salvage rate, overall survival rate, and wound healing rate at 6 and 12 months. Results: A total of 27 studies were included, with 753 patients and 793 limbs. Of the included studies, 16 analyzed the sFVA technique and 11 the pFVA technique. Of the included patients, 86.3% were Rutherford 5/6 in the sFVA group versus 98.4% in the pFVA group. The pooled limb salvage rate at 6 and 12 months was 78.1% and 74.1% in the sFVA group and 81.7% and 78.6% in the pFVA group, respectively. Wound healing rates were not reported in the sFVA group. In the pFVA group, the pooled wound healing rates were 48.1% and 64.5% at 6 and 12 months, respectively. Conclusion: This study showed promising results after FVA among a large population of CLTI patients. In high-risk patients, pFVA is a feasible option with favorable limb salvage and wound healing rates.

18 October 2023 in Journal of Endovascular Therapy
Verified
Journal Article
Open access
MNMichael J. Nugteren
Michael J. Nugteren
CHConstantijn E. V. B. Hazenberg
Constantijn E. V. B. Hazenberg
GAGeorge P. Akkersdijk
George P. Akkersdijk
DHDaniel A. F. van Den Heuvel
Daniel A. F. van Den Heuvel
MSMichiel A. Schreve
Michiel A. Schreve
ÇÜÇağdaş Ünlü
Çağdaş Ünlü
Purpose: Vessel calcification is estimated to be present in 30% to 50% of patients with peripheral arterial disease (PAD) and is one of the main challenges in endovascular treatment. The popliteal artery is unique compared with other arteries due to its exposure to significant deformation and biomechanical stress during knee motion. Intravascular lithotripsy (IVL) is a novel technique that uses acoustic pressure waves to cause microfractures within the intimal and medial wall calcification. Intravascular lithotripsy is safe in femoropopliteal and infrapopliteal lesions, but follow-up studies are lacking. Therefore, the purpose of this study was to describe the first follow-up outcomes of IVL in popliteal and infrapopliteal arterial disease. Methods: This prospective, multicenter cohort study included all patients treated with IVL in the popliteal and infrapopliteal arteries at 4 sites. Standardized follow-up with duplex ultrasonography was scheduled at 6 to 8 weeks and 12 months. The primary safety endpoint was a composite of major adverse events (MAEs) at 30 days. Primary efficacy endpoints were primary patency, limb salvage, and amputation-free survival (AFS) at 12 months. Secondary endpoints were primary-assisted patency and freedom from target lesion revascularization (TLR). Endpoints were distributed for patients with chronic limb–threatening ischemia (CLTI) and intermittent claudication (IC) and estimated using the Kaplan-Meier method. Results: Between April 2021 and March 2023, 29 patients with 30 limbs were treated. Diabetes mellitus (DM) and CLTI were present in 62.1% and 80.0% of patients, respectively. Within the 32 treated lesions, severe calcification was present in 84.4% and bailout stenting was necessary in 12.5% of the lesions. Four MAEs occurred within 30 days: 1 closure device failure, 1 major amputation, and 2 deaths, neither of which was related to the study device. The primary patency, primary-assisted patency, freedom from TLR, limb salvage, and AFS at 12 months were 68.8%, 90.0%, 93.3%, 83.9%, and 57.1% for CLTI patients, respectively. No events occurred in restenosis, re-occlusion, TLR, major amputation, or mortality in patients with IC. Conclusions: This first-ever analysis on follow-up outcomes of IVL in the popliteal and infrapopliteal arteries demonstrated promising safety and efficacy outcomes with a low rate of bailout stenting. Clinical Impact: Vessel calcification is a common feature in peripheral arterial disease (PAD) and is one of the main challenges in endovascular treatment. The popliteal artery is subjected to biomechanical stress during knee motion, which makes stenting unappealing and often leads to worse clinical outcomes. This study aimed to describe the first follow-up outcomes of IVL in popliteal and infrapopliteal arterial disease. As in line with previous studies, no relevant procedural complications were found and the rate of bail-out stenting was only 12.5%. Moreover, in a complex patient population, this study demonstrated promising safety and efficacy outcomes. The comparison of IVL with angioplasty alone or other vessel preparation devices for popliteal and infrapopliteal arterial disease is warranted.

1 October 2020 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
RWRutger H.A. Welling
Rutger H.A. Welling
Gert Jan de BorstGert Jan de Borst
Gert Jan de Borst
DHDaniel A.F. van Den Heuvel
Daniel A.F. van Den Heuvel
PDPD Dr. Dr. Branzan Daniela
PD Dr. Dr. Branzan Daniela
ASAndrej Schmidt
Andrej Schmidt
OBOlaf J. Bakker
Olaf J. Bakker

23 September 2025 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
DHDaniel A.F. van Den Heuvel
Daniel A.F. van Den Heuvel
SKSjors Klompmaker
Sjors Klompmaker
JHJosefien Hessels
Josefien Hessels
ADArjen D. Diederik
Arjen D. Diederik
JMJohannes J. Mager
Johannes J. Mager
MPMarco Post
Marco Post

29 October 2025 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
SGSophie C. Ghijsen
Sophie C. Ghijsen
AMAlexander C.J. de la Mar
Alexander C.J. de la Mar
LKLianne Kalsbeek
Lianne Kalsbeek
DHDaniel A.F. van Den Heuvel
Daniel A.F. van Den Heuvel
OBOlaf J. Bakker
Olaf J. Bakker

21 April 2026 in JVS-Vascular Insights
Verified
Journal Article
Open access
RWRutger H.A. Welling
Rutger H.A. Welling
DHDaniel A.F. van Den Heuvel
Daniel A.F. van Den Heuvel
GBGert J. de Borst
Gert J. de Borst
ASAndrej Schmidt
Andrej Schmidt
OBOlaf J. Bakker
Olaf J. Bakker